Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.40    0.00 (0.00%)
Bid:
4.40
Ask:
4.525
Spread: 0.125 (2.841%)
Market Cap: £211.18m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Director & Senior Management Share Purchase

24 Nov 2011 09:17

RNS Number : 6997S
Seeing Machines Limited
24 November 2011
 



 

 

 

 

Seeing Machines Limited

("Seeing Machines" or the "Company")

 

DIRECTOR & Senior Manager SHARE PURCHASE

Seeing Machines Limited (AIM:SEE), a leading developer of facial image processing software for applications that rely on understanding the movement of human faces and eyes announces that it has today issued 4,730,333 new fully paid ordinary shares ("New Ordinary Shares") to certain Directors and senior managers under the July 2010 Executive Share Plan which was approved at the Annual General Meeting in November 2010. All shares issued under the plan are based on a salary/fee sacrifice arrangement.

Under the plan the Directors' received shares as follows:

Director

Number of New Ordinary Shares

Holding following receipt of New Ordinary Shares

Percentage holding following receipt of New Ordinary Shares

Bill Mobbs1

3,227,527

4,021,312

0.97%

Rob Sale2

269,662

5,757,470

1.39%

David Gaul3

134,831

2,155,779

0.52%

Trent Victor

134,831

371,067

0.09%

1. William Mobbs holds shares in the name of William Mobbs ATF The Bilbo Super Fund

2. Rob Sale's shares are 2,745,715 shares held in the name of Caffe Pty Ltd ATF the R C Sale Superannuation Fund, 2,621,369 shares held by Robert's wife Paula Kay Sale and 390,386 shares held in his own name.

3. David Gaul holds 2,155,779 shares through his company Jaiclimb Pty Limited.

Under the Plan the following senior managers received shares as follows:

Senior Manager

Role

Number of New Ordinary Shares

Holding following receipt of New Ordinary Shares

Percentage holding following receipt of New Ordinary Shares

Nick Cerneaz4

Former CEO

210,674

2,259,788

0.55%

Belinda Burgess5

COO & Company Secretary

415,730

2,817,280

0.68%

Timothy Edwards

Principal Engineer

168,539

21,849,855

5.28%

Sebastien Rougeaux

Principal Research Scientist

168,539

22,343,331

5.40%

4.Nick Cerneaz holds 1,678,006 shares through Cenika Pty Ltd ATF Cenika Super Fund and 581,712 shares in his own name.

5. Belinda Burgess holds 965,870 shares in her own name and 1,851,410 shares in the names Belinda Burgess and Jennifer Kruse as trustees for the Meg & Susie Super Fund.

Application has been made for the New Ordinary Shares to be admitted to trading on AIM. It is expected that admission will occur and that dealings will commence at 8.00 a.m. on 30 November 2011. Immediately following admission of the New Ordinary Shares, the Company will have 413,638,879 fully paid ordinary shares on issue.

 

Enquiries:

 

Seeing Machines Limited

Ken Kroeger, CEO

+61 (0) 2 6103 4700

Daniel Stewart & Company plc

David Hart

+44 (0) 20 7776 6550

Walbrook PR Ltd

+44 (0) 20 7933 8780

Bob Huxford

bob.huxford@walbrookpr.com

Helen Westaway

helen.westaway@walbrookpr.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDKQDDCBDKADB
Date   Source Headline
18th Jun 20267:00 amRNSUS$31m expansion on existing Automotive program
15th Jun 20267:00 amRNSSeeing Machines wins two new Japanese OEM programs
12th May 20267:00 amRNSUS$3.8m Order for Guardian BdMS
6th May 20267:00 amRNSQ3 FY2026 Quarterly KPIs
20th Apr 202612:30 pmRNSHolding(s) in Company
10th Apr 20268:53 amRNSStatement re alleged cyber threat
27th Mar 20267:00 amRNSHalf-year Financial Report
24th Feb 20267:00 amRNS-RPublication of Investor Presentation
18th Feb 20267:00 amRNSTrading Update - H1 FY2026
13th Feb 20267:30 amRNSAppointment of Joint Broker
11th Feb 20267:00 amRNSQ2 FY2026 Quarterly KPIs
13th Jan 202612:00 pmRNS-R3D Cabin Perception Mapping breaks new ground
6th Jan 20267:00 amRNSAgreement
5th Jan 20267:00 amRNSHolding(s) in Company
5th Jan 20267:00 amRNS-R3D Cabin Perception Mapping to be unveiled at CES
2nd Jan 20267:00 amRNS-RSeeing Machines Announces Future Mobility Group
2nd Jan 20267:00 amRNS-RSeeing Machines Announces Future Mobility Group
17th Dec 20257:00 amRNS-RTechnical Paper Series - Intoxication launched
4th Dec 20257:00 amRNS-RSeeing Machines 2025 Guardian Insights Report
27th Nov 20257:00 amRNSResults of AGM
26th Nov 20257:30 amRNSJapanese Auto Award and Extended European Program
12th Nov 20257:05 amRNSQ1 FY2026 Quarterly KPIs
12th Nov 20257:00 amRNSGuardian order from US-based multinational company
6th Nov 20257:05 amRNS-RCollaboration with Magna milestone in China
3rd Nov 20257:00 amRNSBoard Changes
3rd Nov 20257:00 amRNSNotice of Annual General Meeting
30th Oct 20257:00 amRNSLATAM Distributor Orders 1,300 Guardian Units
29th Oct 20257:00 amRNSAdvanced Development Project with Japanese OEM
8th Oct 20257:00 amRNSUS$1.8m expansion order for Guardian BdMS
26th Sep 20257:00 amRNSExpanding Guardian prospects across Europe
25th Sep 20257:00 amRNSFY2025 Results and Annual Financial Report
24th Sep 20257:20 amRNSFirst Guardian contract through Mitsubishi
10th Sep 20257:05 amRNS-RSeeing Machines Launches Impairment Capability
10th Sep 20257:00 amRNSNotice of Results and Presentation
29th Aug 202510:10 amRNSDirector Dealing
21st Aug 20257:00 amRNSFY2025 Trading Update
5th Aug 20257:00 amRNSQ4 FY2025 Quarterly KPIs
30th Jun 20257:00 amRNSMitsubishi Electric Europe Guardian collaboration
27th Jun 20257:00 amRNSUS Guardian Gen 3 trial with Mitsubishi Electric
16th Jun 20258:59 amRNS$1.2 Million Agreement with Global Auto Leader
9th May 20252:31 pmRNSDirector dealing
1st May 20257:00 amRNSQ3 FY2025 Quarterly KPIs
29th Apr 20259:58 amRNSNotification of Major Holdings
8th Apr 20258:53 amRNSHoldings in Company
8th Apr 20257:00 amRNSDirector/PDMR Shareholding
4th Apr 20257:00 amRNSDirector dealing
2nd Apr 202511:00 amRNSLondon presentation for investors and analysts
2nd Apr 20257:00 amRNSDirector dealing
2nd Apr 20257:00 amRNSDirector dealing
1st Apr 202512:00 pmRNS-RSeeing Machines Announces 3D Camera Technology

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.